ADR-58

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameADR-58
Drug Alias NameADR-58
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide aptamer
Mechanisms of ActionIL-6 receptor antagonists
TargetsIL-6 receptor
Therapy Area/IndicationsInflammationArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxo Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxo Group Ltd
Active IndicationsN/A
Inactive IndicationsInflammationArthritis

Other Information

ATC CodeN/A
Related LinksN/A